Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells
- PMID: 2720653
Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells
Abstract
Radio-iodinated m-iodobenzylguanidine (MIBG), an analogue of the neurotransmitter norepinephrine (NE), is increasingly used in the diagnosis and treatment of neural crest tumors. Active uptake and subsequent retention of MIBG and NE was studied in human neuroblastoma SK-N-SH cells. Neuron-specific uptake of [125I]MIBG and [3H]NE saturated at extracellular concentration of 10(-6) M and exceeded by 20-30-fold that by passive diffusion alone. A minimum of 50% of accumulated MIBG remained permanently stored but the SK-N-SH cells were incapable of retaining recaptured [3H]NE. [125I]MIBG was displaced from intracellular binding sites by unlabeled MIBG with 10-fold higher potency than by unlabeled NE. MIBG stored in SK-N-SH cells was insensitive to depletion by the inhibitor of granular uptake reserpine (RSP) and was not precipitated in a granular fraction by differential centrifugation. Only few electron-dense granules were found in these cells by electron microscopy. In contrast, MIBG storage in PC-12 pheochromocytoma cells which contained many storage granules, was sensitive to RSP and part of accumulated drug was recovered in a granular fraction. Accordingly, storage of MIBG in the SK-N-SH neuroblastoma cells is predominantly extravesicular and thus essentially different from that of biogenic amines in normal adrenomedullary tissue or in pheochromocytoma tumors, while sharing with these tissues a common mechanism of active uptake.
Similar articles
-
Extragranular storage of the neuron blocking agent meta-iodobenzylguanidine (MIBG) in human neuroblastoma cells.Biochem Pharmacol. 1990 Jun 15;39(12):1959-64. doi: 10.1016/0006-2952(90)90615-r. Biochem Pharmacol. 1990. PMID: 2353937
-
Biology of metaiodobenzylguanidine interactions with human neuroblastoma cells.J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):186-90. J Nucl Biol Med (1991). 1991. PMID: 1823815
-
Cytotoxic effects of m-[131I]- and m-[125I]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO.Cancer Res. 1988 Jun 1;48(11):2993-7. Cancer Res. 1988. PMID: 3365688
-
Model studies on metaiodobenzylguanidine (MIBG) uptake and storage: relevance for 131I-MIBG therapy of neuroblastoma.J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):191-4. J Nucl Biol Med (1991). 1991. PMID: 1823816 Review. No abstract available.
-
Meta-iodobenzylguanidine and analogues: chemistry and biology.Q J Nucl Med Mol Imaging. 2008 Dec;52(4):351-68. Q J Nucl Med Mol Imaging. 2008. PMID: 19088690 Review.
Cited by
-
A kit method for the high level synthesis of [211At]MABG.Bioorg Med Chem. 2007 May 15;15(10):3430-6. doi: 10.1016/j.bmc.2007.03.016. Epub 2007 Mar 12. Bioorg Med Chem. 2007. PMID: 17387017 Free PMC article.
-
A comparison of iodine-123 meta-iodobenzylguanidine scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma.Eur J Nucl Med. 1993 Dec;20(12):1154-60. doi: 10.1007/BF00171013. Eur J Nucl Med. 1993. PMID: 8299650
-
A model of modified meta-iodobenzylguanidine conjugated gold nanoparticles for neuroblastoma treatment.RSC Adv. 2021 Jul 20;11(41):25199-25206. doi: 10.1039/d1ra04054e. eCollection 2021 Jul 19. RSC Adv. 2021. PMID: 35478920 Free PMC article.
-
Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.Eur J Nucl Med. 1994 Jun;21(6):545-59. doi: 10.1007/BF00173043. Eur J Nucl Med. 1994. PMID: 8082671 Review.
-
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis.Ann Nucl Med. 2021 May;35(5):549-556. doi: 10.1007/s12149-021-01595-7. Epub 2021 Feb 14. Ann Nucl Med. 2021. PMID: 33586098 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical